The Vaccine is called Aidsvax, manufactured at the time by Vaxgen Inc. a pharmaceutical company in the USA. The US Food and Drug Administration (FDA) approved Vaxgen to conduct human tests/trials on June 3rd, 1998. 5000 uninfected volunteers were allowed for testing, 40 clinics in Canada and the USA, and 16 clinics in Thailand were selected to run the tests.
For More Information:
- HIV Vaccine Trials Network – Official Site
We are the worldís largest publicly-funded international collaboration focused on the development of vaccines to prevent HIV/AIDS.
- International AIDS Vaccine Day – acdi-cida.gc.ca – (via the Wayback Machine)
More than 34 million people around the world suffer with HIV and AIDSó95 percent of them in developing countries.
- New AIDS Vaccine Comes in a Capsule – NBC News
Wanted: Volunteers to test an experimental new AIDS vaccine that is needle-free. The catch? You have to be willing to stay locked up in your room for 12 days.
- HIV vaccine
An HIV vaccine is a vaccine which would either protect individuals who do not have HIV from contracting that virus, or otherwise may have a therapeutic effect for persons who have or later contract HIV/AIDS.
- The Canadian HIV Vaccines Plan – PDF
This document is the result of a collaborative process involving researchers, government and the community. In June 2003, Health Canada convened a round-table meeting on HIV vaccines to lay the foundation of a Canadian plan for the development and equitable distribution of HIV vaccines.
June 3rd 1998
Canada, USA, Thailand